Somatic mutation in V-H complementarity-determining region 2 and framework region 2 - Differential effects on antigen binding and Ig secretion

被引:0
|
作者
Wiens, GD
Heldwein, KA
StenzelPoore, MP
Rittenberg, MB
机构
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extent to which somatic mutation impairs the Ig complementarity-determining region (CDR) and framework region (FRW) structure/function is not clear, Previously, we found that the V-H CDR2 of the murine T15 Ab is highly sensitive to mutation; 56% (26 of 46) of Abs mutated in vitro had reduced or no Ag binding capability, and 9% were secretion impaired, Here we test whether the T15 V-H CDR2 structure is unique by mutating the V-H CDR2 of the anti-PC-protein murine Ab, PCG1-1, PCG1-1 V-H is encoded by the M141 gene and is unrelated in sequence or structure to that of T15 V(H)1, The majority (54%, 20 of 37) of PCG1-1 mutants carrying one to five mutations in V-H CDR2 had reduced or abolished Ag binding, while 10% were secretion impaired, Taken together, mutational analysis of the V(H)1 and V-H M141 genes demonstrates that impaired binding and secretion may be common outcomes of CDR2 somatic mutation, We also tested the tolerance of the V-H FRW2 of T15 to mutation, expecting this sequence-conserved region to be highly sensitive to alterations, However, FRW2 accommodated many nonconservative changes, and only 12% (3 of 25) of secreted mutants had impaired Ag binding, Moreover, mutations in FRW2 caused secretion defects in 24% (8 of 33), a frequency twice that of V-H CDR2 mutants, A total of 16 unique secretion mutants have now been identified, These findings suggest that B cell losses from somatic mutation may be extensive and due to varied causes not all related to Ag binding.
引用
收藏
页码:1293 / 1302
页数:10
相关论文
共 50 条
  • [31] Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen
    Moon, Seung Kee
    Park, So Ra
    Park, Ami
    Oh, Hyun Mi
    Shin, Hyun Jung
    Jeon, Eun Ju
    Kim, Seiwhan
    Park, Hyun June
    Yeon, Young Joo
    Yoo, Young Je
    [J]. MOLECULES AND CELLS, 2016, 39 (03) : 217 - 228
  • [32] Extensive framework and complementarity determining region mutations in heavy chain of multireactive pathogenic autoantibodies from BXD2 mice.
    Job, Godwin
    Hsu, Hui-Chen
    Zhang, Jason
    Accavitti-Loper, Mary Ann
    Mountz, John
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S176 - S176
  • [33] β-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma
    Arruda, Denise C.
    Santos, Luana C. P.
    Melo, Filipe M.
    Pereira, Felipe V.
    Figueiredo, Carlos R.
    Matsuo, Alisson L.
    Mortara, Renato A.
    Juliano, Maria A.
    Rodrigues, Elaine G.
    Dobroff, Andrey S.
    Polonelli, Luciano
    Travassos, Luiz R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) : 14912 - 14922
  • [34] IDENTICAL V-REGION AMINO-ACID-SEQUENCES AND SEGMENTS OF SEQUENCES IN ANTIBODIES OF DIFFERENT SPECIFICITIES - RELATIVE CONTRIBUTIONS OF VH AND VL GENES, MINIGENES, AND COMPLEMENTARITY-DETERMINING REGIONS TO BINDING OF ANTIBODY-COMBINING SITES
    KABAT, EA
    WU, TT
    [J]. JOURNAL OF IMMUNOLOGY, 1991, 147 (05): : 1709 - 1719
  • [35] Structural analysis of mutants of high-affinity and low-affinity p-azophenylarsonate-specific antibodies generated by alanine scanning of heavy chain complementarity-determining region 2
    Parhami-Seren, B
    Viswanathan, M
    Strong, RK
    Margolies, MN
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (09): : 5129 - 5135
  • [36] The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5
    Zwick, MB
    Komori, HK
    Stanfield, RL
    Church, S
    Wang, M
    Parren, PWHI
    Kunert, R
    Katinger, H
    Wilson, IA
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (06) : 3155 - 3161
  • [37] IGMS PRODUCED BY 2 ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME LYMPHOMA CELL-LINES - IG BINDING-SPECIFICITY AND V-H-GENE PUTATIVE SOMATIC MUTATION ANALYSIS
    NG, VL
    HURT, MH
    FEIN, CL
    KHAYAMBASHI, F
    MARSH, J
    NUNES, WM
    MCPHAUL, LW
    FEIGAL, E
    NELSON, P
    HERNDIER, BG
    SHIRAMIZU, B
    REYES, GR
    FRY, KE
    MCGRATH, MS
    [J]. BLOOD, 1994, 83 (04) : 1067 - 1078
  • [38] Functional insights of Tyr37 in framework region 2 directly contributing to the binding affinities and dissociation kinetics in single-domain V H H antibodies
    Yamamoto, Koichi
    Nagatoishi, Satoru
    Nakakido, Makoto
    Kuroda, Daisuke
    Tsumoto, Kouhei
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 709
  • [39] Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells
    Dobroff, Andrey S.
    Rodrigues, Elaine G.
    Juliano, Maria A.
    Friaca, Dayson M.
    Nakayasu, Ernesto S.
    Almeida, Igor C.
    Mortara, Renato A.
    Jacysyn, Jacqueline F.
    Amarante-Mendes, Gustavo P.
    Magliani, Walter
    Conti, Stefania
    Polonelli, Luciano
    Travassos, Luiz R.
    [J]. TRANSLATIONAL ONCOLOGY, 2010, 3 (04): : 204 - 217
  • [40] The T Cell Receptor β-Chain Second Complementarity Determining Region Loop (CDR2β) Governs T Cell Activation and Vβ Specificity by Bacterial Superantigens
    Rahman, A. K. M. Nur-Ur
    Bonsor, Daniel A.
    Herfst, Christine A.
    Pollard, Fraser
    Peirce, Michael
    Wyatt, Aaron W.
    Kasper, Katherine J.
    Madrenas, Joaquin
    Sundberg, Eric J.
    McCormick, John K.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) : 4871 - 4881